US 9504671
Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
granted A61KA61K31/407A61K47/10
Quick answer
US patent 9504671 (Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents) held by Xenon Pharmaceuticals Inc. expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Xenon Pharmaceuticals Inc.
- Grant date
- Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/407, A61K47/10, A61K47/14, A61K9/0014